Akèy › HPV
Etid klinik pou HPV ap rekrite nan Etazini
21 etid pou HPV ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Ap rekriteFaz 4Volontè an sante akeyiMande peman pou patisipan yo
Laj 27 a 45 · Fanm · Mizajou Sep 15, 2026 · NCT05672927PopSci CHW4CervixHealth
Ap rekriteVolontè an sante akeyi
Laj 25 a 65 · Fanm · Mizajou Aug 11, 2026 · NCT07336134A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Ap rekriteVolontè an sante akeyi
Laj 25 ak plis · Fanm · Mizajou Jul 31, 2026 · NCT07281430Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening
Ap rekriteVolontè an sante akeyi
Laj 25 ak plis · Fanm · Mizajou Jul 27, 2026 · NCT07453459Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Ap rekriteVolontè an sante akeyi
Laj 25 ak plis · Fanm · Mizajou Jul 24, 2026 · NCT07281599Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT05388773Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Jul 1, 2026 · NCT06210854Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
Ap rekriteVolontè an sante akeyi
Laj 9 a 17 · Tout sèks · Mizajou May 29, 2026 · NCT06380114Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Ap rekrite
Laj 11 a 17 · Tout sèks · Mizajou May 4, 2026 · NCT06598475Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07209189Zopa Retreatment and Vector Shedding in Adults With RRP
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06538480Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
Ap rekriteFaz 2
Laj 25 a 100 · Fanm · Mizajou Oct 2, 2025 · NCT04098744Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
Ap rekriteVolontè an sante akeyi
Laj 18 a 26 · Tout sèks · Mizajou Sep 25, 2025 · NCT06397378Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Aug 14, 2025 · NCT06075264Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
Ap rekriteEtid obsèvasyon
Laj 35 ak plis · Tout sèks · Mizajou Aug 1, 2025 · NCT07087145Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Apr 18, 2025 · NCT05266898HPV Vaccine, Imiquimod, and Metformin Combination Trial
Ap rekriteFaz 2
Laj 18 a 64 · Fanm · Mizajou Nov 13, 2024 · NCT06686043Reducing Urban Cervical Cancer Disparities
Ap rekriteVolontè an sante akeyi
Laj 18 a 90 · Fanm · Mizajou Oct 26, 2024 · NCT06416150PCOM2 - The Physician Communication Intervention, Version 2.0
Ap rekrite
Laj 9 a 17 · Tout sèks · Mizajou Aug 26, 2024 · NCT05336240Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Apr 5, 2024 · NCT05625633Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.